https://www.123articleonline.com/rss/author/415202/dhruv-dhruvvArticles written by DHRUV dhruvv from 123ArticleOnline.comen-usCopyright (c) 123ArticleOnline.com All rights reserved. https://www.123articleonline.com/articles/1439218/parkinsons-disease-drug-pipeline-analysis-2024-trends-key-market-dynamics-and-emerging-therapies Parkinson's disease (PD) is a neurodegenerative disorder that progressively affects motor function, causing symptoms such as tremors, rigidity, and slowed movement. Current treatment options primarily focus on symptom management, as there is no cure for Parkinson's. However, advances in biotechnology and an increased understanding of neurodegenerative diseases have spurred development in the PD drug pipeline. This article provides an in-depth analysis of the Parkinson's disease drug pipeline, discussing market dynamics, trends, segmentation, growth opportunities, and the impact of COVID-19, as well as highlighting key players like Navidea Biopharmaceuticals, CENTOGENE GmbH, UCB Biopharma, and Chongqing Fortune Pharmaceutical.